Definitive Contract 75P00120C00030

Award Date 4/8/20
Potential Completion Date 1/30/23
Potential Value $428M
Ultimate Awardee
Rite Aid Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price Incentive
Place of Performance
Camp Hill, PA 17011, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Quest Diagnostics Incorporated, doing business as Quest Diagnostics, has been awarded a definitive contract valued at approximately $16.8 million by the Department of Health and Human Services Office of the Assistant Secretary for Administration to provide COVID-19 self-swab and point-of-care testing as part of a public-private partnership. Performance will take place in Bentonville, Arkansas over approximately 15 months through February 2021. The fixed-price incentive contract supports the...
E3Health Solutions, LLC was awarded a $415.9 million definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Administration to provide COVID-19 self-swab and point-of-care testing as part of a public-private partnership. The contract is for a base period of performance ending September 30, 2021 to support the Coronavirus COVID-19 National Interest Action. E3Health Solutions will deliver testing services from its location in Mansfield, Texas...
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Walgreens (Walgreen CO.) with a Ceiling Value of $306,212,245.35. The contract, titled "Increasing Community Access to Testing (ICATT)", is for maintaining approximately 20,000 pharmacy and community-based COVID-19 testing sites nationwide through June 2028. The contract has a 6-month base period and five 6-month option periods. This is not a set-aside requirement, and the NAICS code is...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Laboratory Corporation of America Holdings, a global life sciences company. The $169,142.60 firm-fixed-price purchase order is to support the supply of COVID-19 at-home test kits for fiscal year 2020. The contract does not have a set-aside designation. Laboratory Corporation of America Holdings has previously provided serology testing...
This is a $521,374,747.80 firm fixed-price delivery order contract awarded to Quidel Corp, a manufacturer of medical diagnostics and supplies, by the Defense Logistics Agency Troop Support Medical for QuickVue At-Home Over-The-Counter COVID-19 test kits. The contract has an ultimate completion date of February 13, 2024 and was awarded on October 20, 2021 without any set-aside designations. This contract represents a strategic partnership between Quidel and the federal government in addressing...
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to Aptitude Medical Systems Inc. The contract is for the development of the ACE Rapid Molecular Test System, a COVID-19 testing solution for point-of-care and in-home use with saliva and swab samples. The definitive, cost-plus-fixed-fee contract has a ceiling value of $61,969,604.00 and a completion date...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563334408 QuickVue At-Home COVID-19 tests. The $1,700.00 order, which has a completion date of January 17, 2024, is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous prior contracts from DLA to provide pharmaceuticals, medical supplies, and...
This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $61,236,000 firm fixed-price definitive contract to Azure Medical, Inc., a minority-owned small disadvantaged business, for the delivery of over-the-counter (OTC) COVID-19 tests. The contract, which has a period of performance through March 19, 2025, was awarded on September 20, 2023 and does not have a set-aside designation. As a manufacturer of goods, Azure...
The Defense Health Agency awarded Roche Diagnostics Corporation a $500,000 firm fixed price blanket purchase agreement call contract to provide reagents and test kits for COVID-19 testing. The contract was awarded under the National Interest Action Code for coronavirus response and will be performed in Bethesda, Maryland through August 2021. As the prime contractor, Roche will support the Defense Health Agency's efforts to expand COVID-19 testing capacity. No subcontractors or set aside...

The Department of Health and Human Services awarded Rite Aid Hdqtrs. Corp. a $427.8 million definitive contract to support COVID-19 self-swab and point-of-care testing through a public-private partnership. As the prime contractor, Rite Aid will leverage its existing retail infrastructure and laboratory facilities to expand nationwide access to diagnostic screening. Testing services will be provided from Rite Aid locations in Camp Hill, Pennsylvania through January 2023. No subcontractors or set-aside designations were indicated. This large-scale initiative by HHS underscores the importance of engaging private sector partners to bolster the public health response through accessible and timely testing throughout the pandemic recovery period.

Generated 12/29/23, 3:57 PM